<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38274344</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1792-1015</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>Lung function at three months after hospitalization due to COVID&#x2011;19 pneumonia: Comparison of alpha, delta and omicron variant predominance periods.</ArticleTitle><Pagination><StartPage>83</StartPage><MedlinePgn>83</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">83</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2024.12372</ELocationID><Abstract><AbstractText>The coronavirus disease (COVID-19) pandemic has already affected millions of individuals, with increasing numbers of survivors. These data suggest that the pulmonary sequelae of the infection may have an effect on a wide range of individuals. The aim of the present study was to evaluate pulmonary function in patients hospitalized due to COVID-19 three months after hospital discharge. A total of 116 patients, 34 females and 82 males, with a mean age of 57.77&#xb1;11.45 years, who were hospitalized due to COVID-19, underwent pulmonary function testing three months after their hospital discharge. Of these, 83 (71.6%) patients were hospitalized in the period of alpha variant predominance, 16 (13.8%) in the period of delta variant predominance and 17 (14.6%) in the omicron variant predominance period. The mean value of diffusion capacity for carbon monoxide (DLCO)% predicted (pred) was statistically higher in patients affected by the omicron variant (P=0.028). Abnormal values (&lt;80% pred) of DLCO and total lung capacity (TLC) were observed in 28.4 and 20.7% of the patients, respectively. Active smoking was an independent predictor of abnormal values of forced expiratory volume in 1 sec % pred and TLC% pred [P=0.038; odds ratio (OR): 8.574, confidence interval (CI) 1.124-65.424 and P=0.004, OR: 14.733, CI 2.323-93.429, respectively], age was an independent predictor of abnormal values of forced vital capacity % pred and DLCO% pred (P=0.027, OR: 1.124, CI 1.014-1.246 and P=0.011, OR:1.054, CI 1.012-1.098, respectively); and female sex was an independent predictor of abnormal values of DLCO% pred (P=0.009, OR: 1.124, CI 1.014-1.246). &#x391; significant percentage of hospitalized patients due to COVID-19 pneumonia will develop abnormal pulmonary function, regardless of the SARS-CoV-2 variant.</AbstractText><CopyrightInformation>Copyright: &#xa9; Georgakopoulou et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Georgakopoulou</LastName><ForeName>Vasiliki Epameinondas</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makrodimitri</LastName><ForeName>Sotiria</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gkoufa</LastName><ForeName>Aikaterini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostolidi</LastName><ForeName>Eirini</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Provatas</LastName><ForeName>Sotirios</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ENT Department, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papalexis</LastName><ForeName>Petros</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Endocrinology, First Department of Propedeutic and Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spandidos</LastName><ForeName>Demetrios A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lempesis</LastName><ForeName>Ioannis G</ForeName><Initials>IG</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gamaletsou</LastName><ForeName>Maria N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sipsas</LastName><ForeName>Nikolaos V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and COVID-19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diffusion capacity for carbon monoxide</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">lung function</Keyword><Keyword MajorTopicYN="N">spirometry</Keyword><Keyword MajorTopicYN="N">total lung capacity</Keyword></KeywordList><CoiStatement>DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>3</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38274344</ArticleId><ArticleId IdType="pmc">PMC10809351</ArticleId><ArticleId IdType="doi">10.3892/etm.2024.12372</ArticleId><ArticleId IdType="pii">ETM-27-2-12372</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R.  Features, evaluation, and treatment of coronavirus (COVID-19) [Updated 2023 Aug 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:  https://www.ncbi.nlm.nih.gov/books/NBK554776/.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheleme T, Bekele F, Ayela T. Clinical presentation of patients infected with coronavirus disease 19: A systematic review. Infect Dis (Auckl) 2020;13(1178633720952076) doi: 10.1177/1178633720952076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178633720952076</ArticleId><ArticleId IdType="pmc">PMC7495523</ArticleId><ArticleId IdType="pubmed">32973375</ArticleId></ArticleIdList></Reference><Reference><Citation>Siafarikas C, Stafylidis C, Tentolouris A, Samara S, Eliadi I, Makrodimitri S, Spandidos DA, Mathioudakis N, Karamichalos P, Papalexis P, et al. Radiologically suspected COVID-19-associated organizing pneumonia responding well to corticosteroids: A report of two cases and a review of the literature. Exp Ther Med. 2022;24(453) doi: 10.3892/etm.2022.11379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11379</ArticleId><ArticleId IdType="pmc">PMC9199065</ArticleId><ArticleId IdType="pubmed">35720626</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou VE, Gkoufa A, Damaskos C, Papalexis P, Pierrakou A, Makrodimitri S, Sypsa G, Apostolou A, Asimakopoulou S, Chlapoutakis S, et al. COVID-19-associated acute appendicitis in adults. A report of five cases and a review of the literature. Exp Ther Med. 2022;24(482) doi: 10.3892/etm.2022.11409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11409</ArticleId><ArticleId IdType="pmc">PMC9214594</ArticleId><ArticleId IdType="pubmed">35761802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cholongitas E, Bali T, Georgakopoulou VE, Giannakodimos A, Gyftopoulos A, Georgilaki V, Gerogiannis D, Basoulis D, Eliadi I, Karamanakos G, et al. Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients' outcomes: A single-center Greek study. Ann Gastroenterol. 2022;35:290&#x2013;296. doi: 10.20524/aog.2022.0709.</Citation><ArticleIdList><ArticleId IdType="doi">10.20524/aog.2022.0709</ArticleId><ArticleId IdType="pmc">PMC9062840</ArticleId><ArticleId IdType="pubmed">35599935</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou VE, Avramopoulos P, Papalexis P, Bitsani A, Damaskos C, Garmpi A, Venetikou MS, Paramythiotis D, Karlafti E, Sklapani P, et al. COVID-19 induced hypoparathyroidism: A case report. Exp Ther Med. 2022;23(346) doi: 10.3892/etm.2022.11276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11276</ArticleId><ArticleId IdType="pmc">PMC8988155</ArticleId><ArticleId IdType="pubmed">35401797</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou VE, Gkoufa A, Garmpis N, Makrodimitri S, Papageorgiou CV, Barlampa D, Garmpi A, Chiapoutakis S, Sklapani P, Trakas N, Damaskos C. COVID-19 and acute pancreatitis: A systematic review of case reports and case series. Ann Saudi Med. 2022;42:276&#x2013;287. doi: 10.5144/0256-4947.2022.276.</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2022.276</ArticleId><ArticleId IdType="pmc">PMC9357298</ArticleId><ArticleId IdType="pubmed">35933608</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk factors associated with Acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou VE, Gkoufa A, Bougea A, Basoulis D, Tsakanikas A, Makrodimitri S, Karamanakos G, Spandidos DA, Angelopoulou E, Sipsas NV. Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID-19-associated pneumonia. Med Int (Lond) 2023;3(34) doi: 10.3892/mi.2023.94.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mi.2023.94</ArticleId><ArticleId IdType="pmc">PMC10336924</ArticleId><ArticleId IdType="pubmed">37448768</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkoufa A, Maneta E, Ntoumas GN, Georgakopoulou VE, Mantelou A, Kokkoris S, Routsi C. Elderly adults with COVID-19 admitted to intensive care unit: A narrative review. World J Crit Care Med. 2021;10:278&#x2013;289. doi: 10.5492/wjccm.v10.i5.278.</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v10.i5.278</ArticleId><ArticleId IdType="pmc">PMC8462023</ArticleId><ArticleId IdType="pubmed">34616662</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempesis IG, Georgakopoulou VE. Implications of obesity and adiposopathy on respiratory infections; focus on emerging challenges. World J Clin Cases. 2023;11:2925&#x2013;2933. doi: 10.12998/wjcc.v11.i13.2925.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v11.i13.2925</ArticleId><ArticleId IdType="pmc">PMC10198078</ArticleId><ArticleId IdType="pubmed">37215426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, Singh U, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Kympouropoulos SP, Tsoporis JN, Spandidos DA, et al. Long COVID and neuropsychiatric manifestations (review) Exp Ther Med. 2022;23(363) doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Demetriou M, Siafakas N, Katsantoni E, Makris M, Tsivgoulis G, Zoumpourlis V, Kympouropoulos SP, Tsoporis JN, et al. New-onset neuropsychiatric sequelae and &#x2018;long-COVID&#x2019; syndrome (Review) Exp Ther Med. 2022;24(705) doi: 10.3892/etm.2022.11641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11641</ArticleId><ArticleId IdType="pmc">PMC9622976</ArticleId><ArticleId IdType="pubmed">36324612</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373(n1098) doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>E E, R F, &#xd6;i E, Im L, M L, S R, E W, C J, M H, A M. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021;182(106394) doi: 10.1016/j.rmed.2021.106394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106394</ArticleId><ArticleId IdType="pmc">PMC8047337</ArticleId><ArticleId IdType="pubmed">33901787</ArticleId></ArticleIdList></Reference><Reference><Citation>Riou M, MarcoT C, Oulehri W, Enache I, Pistea C, Chatron E, Labani A, Geny B, Ohana M, De Blay F, et al. Respiratory follow-up after hospitalization for COVID-19: Who and when? Eur J Clin Invest. 2021;51(e13603) doi: 10.1111/eci.13603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13603</ArticleId><ArticleId IdType="pmc">PMC8209926</ArticleId><ArticleId IdType="pubmed">33998683</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AS, Wong AW, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, Carlsten C. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76:402&#x2013;404. doi: 10.1136/thoraxjnl-2020-216308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: A systematic review and meta-analysis. Respir Res. 2022;23(233) doi: 10.1186/s12931-022-02163-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02163-x</ArticleId><ArticleId IdType="pmc">PMC9446643</ArticleId><ArticleId IdType="pubmed">36068582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K, Chen H, Zeng Z, Qin Y, Wang H, et al. Twelve-month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: A prospective cohort study in Wuhan, China. Clin Infect Dis. 2022;74:1953&#x2013;1965. doi: 10.1093/cid/ciab703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab703</ArticleId><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after omicron emerged in the US medRxiv: Feb 22, 2022 (Epub ahead of print).</Citation></Reference><Reference><Citation>Abdullah F, Myers J, Basu D, Tintinger G, Ueckermann V, Mathebula M, Ramlall R, Spoor S, de Villiers T, Van der Walt Z, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2022;116:38&#x2013;42. doi: 10.1016/j.ijid.2021.12.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.357</ArticleId><ArticleId IdType="pmc">PMC8713416</ArticleId><ArticleId IdType="pubmed">34971823</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi M, Al-Najjar Y, Mhaimeed N, Salameh MA, Paul P, AlAnni J, Abdelati AA, Laswi I, Khanjar B, Al-Ali D, et al. Severity of the omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review. J Cell Mol Med. 2023;27:1443&#x2013;1464. doi: 10.1111/jcmm.17747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.17747</ArticleId><ArticleId IdType="pmc">PMC10243162</ArticleId><ArticleId IdType="pubmed">37203288</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. 1993;16:5&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">8499054</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou VE, Asimakopoulou S, Cholongitas E. Pulmonary function testing in patients with liver cirrhosis (review) Med Int (Lond) 2023;3(36) doi: 10.3892/mi.2023.96.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mi.2023.96</ArticleId><ArticleId IdType="pmc">PMC10391595</ArticleId><ArticleId IdType="pubmed">37533800</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC. Standardization of the measurement of transfer factor (diffusing capacity) Eur Respir J. 1993;6 (Suppl 16):S41&#x2013;S52. doi: 10.1183/09041950.041s1693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09041950.041s1693</ArticleId><ArticleId IdType="pubmed">24576916</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampitsakos T, Sotiropoulou V, Katsaras M, Tsiri P, Georgakopoulou VE, Papanikolaou IC, Bibaki E, Tomos I, Lambiri I, Papaioannou O, et al. Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model. Front Med (Lausanne) 2023;9(1083264) doi: 10.3389/fmed.2022.1083264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1083264</ArticleId><ArticleId IdType="pmc">PMC9886681</ArticleId><ArticleId IdType="pubmed">36733935</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, et al. 1-Year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ramasamy A, Verduzco-Gutierrez M, Brode WM, Melamed E. Acute and post-acute sequelae of SARS-CoV-2 infection: A review of risk factors and social determinants. Virol J. 2023;20(124) doi: 10.1186/s12985-023-02061-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02061-8</ArticleId><ArticleId IdType="pmc">PMC10276420</ArticleId><ArticleId IdType="pubmed">37328773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarraso J, Safont B, Carbonell-Asins JA, Fernandez-Fabrellas E, Sancho-Chust JN, Naval E, Amat B, Herrera S, Ros JA, Soler-Catalu&#xf1;a JJ, et al. Lung function and radiological findings 1 year after COVID-19: A prospective follow-up. Respir Res. 2022;23(242) doi: 10.1186/s12931-022-02166-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02166-8</ArticleId><ArticleId IdType="pmc">PMC9466319</ArticleId><ArticleId IdType="pubmed">36096801</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell. 2021;184:1990&#x2013;2019. doi: 10.1016/j.cell.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC8052295</ArticleId><ArticleId IdType="pubmed">33811810</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghali A, Koloko Ngassie ML, Pabelick CM, Prakash YS. Cellular senescence in aging lungs and diseases. Cells. 2022;11(1781) doi: 10.3390/cells11111781.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11111781</ArticleId><ArticleId IdType="pmc">PMC9179897</ArticleId><ArticleId IdType="pubmed">35681476</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SJ, Stout-Delgado HW. Aging and lung disease. Annu Rev Physiol. 2020;82:433&#x2013;459. doi: 10.1146/annurev-physiol-021119-034610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-021119-034610</ArticleId><ArticleId IdType="pmc">PMC7998901</ArticleId><ArticleId IdType="pubmed">31730381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, Clark A, Ntatsaki E, Vassiliou VS. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, Augello M, Mondatore D, Allegrini M, Cona A, et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin Microbiol Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19: Middle aged women face greater risk of debilitating long term symptoms. BMJ. 2021;372(n829) doi: 10.1136/bmj.n829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Investig Med. 2023;71:545&#x2013;562. doi: 10.1177/10815589231158041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyris M, Mej&#xed;a JE, Chaumeil J, Gu&#xe9;ry JC. Female predisposition to TLR7-driven autoimmunity: Gene dosage and the escape from X chromosome inactivation. Semin Immunopathol. 2019;41:153&#x2013;164. doi: 10.1007/s00281-018-0712-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0712-y</ArticleId><ArticleId IdType="pubmed">30276444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanidziar D, Robson SC. Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021;320:L12&#x2013;L16. doi: 10.1152/ajplung.00304.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00304.2020</ArticleId><ArticleId IdType="pmc">PMC7816427</ArticleId><ArticleId IdType="pubmed">33050737</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, et al. Pulmonary angiopathy in severe COVID-19: Physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202:690&#x2013;699. doi: 10.1164/rccm.202004-1412OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1412OC</ArticleId><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Silveyra P, Fuentes N, Rodriguez Bauza DE. Sex and gender differences in lung disease. Adv Exp Med Biol. 2021;1304:227&#x2013;258. doi: 10.1007/978-3-030-68748-9_14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-68748-9_14</ArticleId><ArticleId IdType="pmc">PMC8221458</ArticleId><ArticleId IdType="pubmed">34019273</ArticleId></ArticleIdList></Reference><Reference><Citation>Trakas N, Georgakopoulou VE, Melemeni D, Damaskos C, Mantzouranis K, Garmpis N, Gkoufa A, Papalexis P, Chlapoutakis S, Sklapani P, et al. Association between smoking cessation and alterations in forced expiratory volume in one second (FEV1). A follow-up study from a Greek tobacco cessation clinic. Addict Health. 2022;14:87&#x2013;95. doi: 10.22122/AHJ.2022.196722.1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.22122/AHJ.2022.196722.1244</ArticleId><ArticleId IdType="pmc">PMC9743813</ArticleId><ArticleId IdType="pubmed">36544517</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;l&#xe9;my H, Mougenot E, Duracinsky M, Salmon-Ceron D, Bonini J, P&#xe9;retz F, Chassany O, Carrieri P. Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey. Tob Induc Dis. 2022;20(59) doi: 10.18332/tid/150295.</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/150295</ArticleId><ArticleId IdType="pmc">PMC9204712</ArticleId><ArticleId IdType="pubmed">35799625</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Pitre PJ, Sabbula BR, Cascella M.  Restrictive lung disease. In: StatPearls. StatPearls Publishing, Treasure Island, FL, 2023. Available from:  https://www.ncbi.nlm.nih.gov/books/NBK560880/.</Citation><ArticleIdList><ArticleId IdType="pubmed">32809715</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>